Loading...
Houlihan Lokey Inc (HLI) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown strong financial performance in its latest quarter, the technical indicators are mixed, and there is significant insider and hedge fund selling activity. Additionally, there are no recent positive trading signals or news catalysts to justify immediate action.
The MACD is positive and expanding, suggesting bullish momentum. However, the RSI is neutral at 58.584, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 167.111, with resistance at 171.485 and support at 162.737.

Strong financial performance in Q3 2026, with revenue up 13.03% YoY, net income up 22.29% YoY, and EPS up 22.30% YoY.
Significant insider selling (up 881% last month) and hedge fund selling (up 102.34% last quarter). No recent news or congress trading data. Mixed analyst ratings with some price target reductions.
In Q3 2026, revenue increased to $717.07M (up 13.03% YoY), net income increased to $116.55M (up 22.29% YoY), and EPS increased to 1.7 (up 22.30% YoY).
Mixed ratings: UBS raised its price target to $196 with a Neutral rating, while BMO Capital and Keefe Bruyette maintain Outperform ratings with price targets of $211 and $214, respectively. However, Keefe Bruyette has been lowering its price targets over time, and Goldman Sachs recently removed HLI from its US Conviction List.